Physician

Todd M Waldmann, M.D.

According to 2025 Medicare claims, Todd Waldmann, M.D. (NPI: 1104877299) practices urology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is IDAHO UROLOGIC INSTITUTE PA (NPI: 1689620692; TIN: 20-1300128) and primary practice location at 83642-6245. Waldmann is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Waldmann's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 697 traditional Medicare patients, billed 14,325 HCPCS/CPT codes, and received $256,694 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,032 prescription claims across 500 beneficiaries totaling $1,528,829 in drug costs, led by Nubeqa (Darolutamide). DME data shows 130 claims. Open Payments data shows 6 records totaling $100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $200,754 and ending at $256,694. Concurrently, Part D prescription costs have risen steadily, from $210,182 to $1,528,829. In contrast, DME billing represents a smaller volume and declined steadily, from $845 to $447.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	540	31,686	$200,754
2016	525	25,570	$272,990
2017	543	17,404	$288,641
2018	669	19,521	$329,126
2019	836	17,028	$289,443
2020	793	21,998	$227,535
2021	661	12,199	$222,997
2022	693	15,717	$343,830
2023	742	23,158	$338,881
2024	697	14,325	$256,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	289	1,497	$210,182
2016	331	1,686	$440,612
2017	342	1,658	$698,999
2018	356	1,722	$1,008,692
2019	387	1,728	$1,644,767
2020	394	1,962	$1,377,303
2021	422	1,917	$1,156,713
2022	438	1,925	$1,166,481
2023	467	1,859	$1,170,701
2024	500	2,032	$1,528,829

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	109	$12,671
2016	12	159	$25,455
2017	15	231	$45,816
2018	N/R	232	$35,926
2019	N/R	185	$35,324
2020	12	225	$45,389
2021	N/R	205	$36,784
2022	N/R	142	$47,496
2023	13	135	$57,365
2024	13	130	$63,894

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	242	355	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	262	308	$54
84153	Psa (prostate specific antigen) measurement, total	252	362	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	205	223	$11
81001	Manual urinalysis test with examination using microscope, automated	396	559	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nubeqa	Darolutamide	57	1,710	$679,259
Xtandi	Enzalutamide	22	660	$267,849
Abiraterone Acetate	Abiraterone Acetate	149	4,470	$202,461
Erleada	Apalutamide	11	330	$149,026
Myrbetriq	Mirabegron	63	3,500	$51,891

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	13	47	$55,262
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	53	$8,287
A4332	Lubricant, individual sterile packet, each	N	N/R	30	$346

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$100	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$107,777	SN Holdings, LLC

Explore More Providers

FAQ

What Medicare data is available for Todd M. Waldmann, M.D.?

Tedicare shows public-source Medicare data for Todd M. Waldmann, M.D. (NPI 1104877299), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd M. Waldmann, M.D. have ACO affiliation data?

Todd M. Waldmann, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Todd M. Waldmann, M.D.?

Todd M. Waldmann, M.D. is linked to IDAHO UROLOGIC INSTITUTE PA (billing NPI 1689620692) in the available physician profile data.

Does Todd M. Waldmann, M.D. have Open Payments data?

Todd M. Waldmann, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.